Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Current Assets (2021 - 2025)

Core Scientific's Current Assets history spans 5 years, with the latest figure at $1.1 billion for Q3 2025.

  • For Q3 2025, Current Assets changed N/A year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $1.1 billion, changed N/A, while the annual FY2024 figure was $904.0 million, 831.77% up from the prior year.
  • Current Assets for Q3 2025 was $1.1 billion at Core Scientific, up from $833.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.1 billion in Q3 2025 and bottomed at $2.0 million in Q3 2021.
  • The 5-year median for Current Assets is $134.7 million (2023), against an average of $346.2 million.
  • The largest YoY upside for Current Assets was 29480.72% in 2022 against a maximum downside of 88.75% in 2022.
  • A 5-year view of Current Assets shows it stood at $756.6 million in 2021, then plummeted by 88.75% to $85.1 million in 2022, then rose by 14.0% to $97.0 million in 2023, then skyrocketed by 831.77% to $904.0 million in 2024, then grew by 17.38% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Current Assets are $1.1 billion (Q3 2025), $833.2 million (Q1 2025), and $904.0 million (Q4 2024).